Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription 18.02.2019 8 Ann Surg Oncol 9 BMC Cancer 1 Cancer Lett 1 Cancer Res 1 Curr Treat Options Oncol 2 Dis Colon Rectum 1 Hum Pathol 2 Int J Cancer 2 Int J Colorectal Dis 1 Lancet 1 Oncogene 1 Oncology 4 PLoS One 2 Semin Oncol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Surg Oncol

1. SPASOJEVIC M, Mariathasan AB, Goscinski M, Thorgersen EB, et al
   Vertical Rectus Abdominis Musculocutaneous Flap Repair Improves Perineal Wound Healing after Abdominoperineal Resection for Irradiated Locally Advanced Rectal Cancer.
   Ann Surg Oncol. 2018;25:1357-1365.
   PubMed     Text format     Abstract available
   
   
2. WASIF N, Etzioni D, Habermann EB, Mathur A, et al
   Racial and Socioeconomic Differences in the Use of High-Volume Commission on Cancer-Accredited Hospitals for Cancer Surgery in the United States.
   Ann Surg Oncol. 2018;25:1116-1125.
   PubMed     Text format     Abstract available
   
   
3. VIGANO L, Darwish SS, Rimassa L, Cimino M, et al
   Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?
   Ann Surg Oncol. 2018;25:1676-1685.
   PubMed     Text format     Abstract available
   
   
4. GOFFREDO P, Garancini M, Robinson TJ, Frakes J, et al
   A National-Level Validation of the New American Joint Committee on Cancer 8th Edition Subclassification of Stage IIA and B Anal Squamous Cell Cancer.
   Ann Surg Oncol. 2018;25:1654-1660.
   PubMed     Text format     Abstract available
   
   
5. FIORENTINI G, Ratti F, Cipriani F, Catena M, et al
   Tips and Tricks for a Laparoscopic Approach to Paracaval Liver Segments.
   Ann Surg Oncol. 2018;25:1695-1698.
   PubMed     Text format     Abstract available
   
   
6. HAMABE A, Park S, Morita S, Tanida T, et al
   Analysis of the Vascular Interrelationships Among the First Jejunal Vein, the Superior Mesenteric Artery, and the Middle Colic Artery.
   Ann Surg Oncol. 2018;25:1661-1667.
   PubMed     Text format     Abstract available
   
   
7. ROUANET P, Bertrand MM, Jarlier M, Mourregot A, et al
   Robotic Versus Laparoscopic Total Mesorectal Excision for Sphincter-Saving Surgery: Results of a Single-Center Series of 400 Consecutive Patients and Perspectives.
   Ann Surg Oncol. 2018;25:3572-3579.
   PubMed     Text format     Abstract available
   
   
8. CLEARY RK, Morris AM, Chang GJ, Halverson AL, et al
   Controversies in Surgical Oncology: Does the Minimally Invasive Approach for Rectal Cancer Provide Equivalent Oncologic Outcomes Compared with the Open Approach?
   Ann Surg Oncol. 2018;25:3587-3595.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

9. YU P, Zhou M, Qu J, Fu L, et al
   The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients.
   BMC Cancer. 2018;18:1076.
   PubMed     Text format     Abstract available
   
   
10. ASHKTORAB H, Rahi H, Nouraie M, Shokrani B, et al
    GPNMB methylation: a new marker of potentially carcinogenic colon lesions.
    BMC Cancer. 2018;18:1068.
    PubMed     Text format     Abstract available
    
    
11. NAGATA N, Nishijima T, Niikura R, Yokoyama T, et al
    Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study.
    BMC Cancer. 2018;18:1066.
    PubMed     Text format     Abstract available
    
    
12. PENNEY ME, Parfrey PS, Savas S, Yilmaz YE, et al
    A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
    BMC Cancer. 2019;19:133.
    PubMed     Text format     Abstract available
    
    
13. BELLUCO C, Forlin M, Delrio P, Rega D, et al
    Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    BMC Cancer. 2018;18:1094.
    PubMed     Text format     Abstract available
    
    
14. CHEN M, Sharma A, Lin Y, Wu Y, et al
    Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells.
    BMC Cancer. 2019;19:153.
    PubMed     Text format     Abstract available
    
    
15. ERIKSEN AC, Sorensen FB, Lindebjerg J, Hager H, et al
    Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort.
    BMC Cancer. 2019;19:142.
    PubMed     Text format     Abstract available
    
    
16. CHARETTE N, Vandeputte C, Ameye L, Bogaert CV, et al
    Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
    BMC Cancer. 2019;19:134.
    PubMed     Text format     Abstract available
    
    
17. LILES EG, Perrin N, Rosales AG, Smith DH, et al
    Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study.
    BMC Cancer. 2018;18:509.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

18. YU L, Dong L, Wang Y, Liu L, et al
    Reversible Regulation of SATB1 Ubiquitination by USP47 and SMURF2 Mediates Colon Cancer Cell Proliferation and Tumor Progression.
    Cancer Lett. 2019 Feb 8. pii: S0304-3835(19)30068.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

19. TAKEDA M, Koseki J, Takahashi H, Miyoshi N, et al
    Disruption of endolysosomal RAB5/7 efficiently eliminates colorectal cancer stem cells.
    Cancer Res. 2019 Feb 14. pii: 0008-5472.CAN-18-2192.
    PubMed     Text format     Abstract available
    
    

    
    Curr Treat Options Oncol

20. TROSMAN J, Weldon C, Kircher S, Gradishar W, et al
    Innovating Cancer Care Delivery: the Example of the 4R Oncology Model for Colorectal Cancer Patients.
    Curr Treat Options Oncol. 2019;20:11.
    PubMed     Text format     Abstract available
    
    

    
    Dis Colon Rectum

21. HOEHN RS, Smith JJ
    Adjuvant Chemotherapy for Colon Cancer.
    Dis Colon Rectum. 2019;62:274-278.
    PubMed     Text format    
    
    
22. CONNELL LC, Cercek A
    Expert Commentary on Adjuvant Chemotherapy for Colon Cancer.
    Dis Colon Rectum. 2019;62:278.
    PubMed     Text format    
    
    

    
    Hum Pathol

23. SINHA N, Gaston D, Manders D, Goudie M, et al
    Characterization of genome-wide copy number aberrations in colonic mixed adenoneuroendocrine carcinoma and neuroendocrine carcinoma reveals recurrent amplification of PTGER4 and MYC genes.
    Hum Pathol. 2018;73:16-25.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

24. ETEMADI A, Abnet CC, Graubard BI, Beane-Freeman L, et al
    Anatomical subsite can modify the association between meat and meat compounds and risk of colorectal adenocarcinoma: Findings from three large US cohorts.
    Int J Cancer. 2018;143:2261-2270.
    PubMed     Text format     Abstract available
    
    
25. ALNABULSI A, Cash B, Hu Y, Silina L, et al
    The expression of brown fat associated proteins in colorectal cancer and the relationship of uncoupling protein 1 with prognosis.
    Int J Cancer. 2019 Feb 8. doi: 10.1002/ijc.32198.
    PubMed     Text format     Abstract available
    
    

    
    Int J Colorectal Dis

26. MIYAKE H, Murono K, Nagata H, Nozawa H, et al
    Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer.
    Int J Colorectal Dis. 2019 Feb 9. pii: 10.1007/s00384-019-03259.
    PubMed     Text format     Abstract available
    
    
27. MOHAMED I, Chan S, Bhangu A, Karandikar S, et al
    Correction to: Appendicitis as a manifestation of colon cancer: should we image the colon after appendicectomy in patients over the age of 40 years?
    Int J Colorectal Dis. 2019 Feb 15. pii: 10.1007/s00384-019-03262.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

28. DEKKER E, Kaminski MF
    Take a pill for no more polyps: is it that simple?
    Lancet. 2018;392:2519-2521.
    PubMed     Text format    
    
    

    
    Oncogene

29. ZHAO GX, Xu YY, Weng SQ, Zhang S, et al
    CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation.
    Oncogene. 2019 Feb 11. pii: 10.1038/s41388-019-0740.
    PubMed     Text format     Abstract available
    
    

    
    Oncology

30. KOBAYASHI K, Kawakami K, Yokokawa T, Aoyama T, et al
    Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer.
    Oncology. 2019 Feb 14:1-7. doi: 10.1159/000495989.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

31. KAPRIO T, Rasila T, Hagstrom J, Mustonen H, et al
    Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer.
    PLoS One. 2019;14:e0211564.
    PubMed     Text format     Abstract available
    
    
32. KLOSE J, Trefz S, Wagner T, Steffen L, et al
    Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model.
    PLoS One. 2019;14:e0211916.
    PubMed     Text format     Abstract available
    
    
33. RODRIGUEZ-ALONSO L, Rodriguez-Moranta F, Arajol C, Gilabert P, et al
    Proton pump inhibitors reduce the accuracy of faecal immunochemical test for detecting advanced colorectal neoplasia in symptomatic patients.
    PLoS One. 2018;13:e0203359.
    PubMed     Text format     Abstract available
    
    
34. REDFORD L, Alhilal G, Needham S, O'Brien O, et al
    A novel panel of short mononucleotide repeats linked to informative polymorphisms enabling effective high volume low cost discrimination between mismatch repair deficient and proficient tumours.
    PLoS One. 2018;13:e0203052.
    PubMed     Text format     Abstract available
    
    

    
    Semin Oncol

35. SCHIRRIPA M, Cohen SA, Battaglin F, Lenz HJ, et al
    Biomarker-driven and molecular targeted therapies for colorectal cancers.
    Semin Oncol. 2018;45:124-132.
    PubMed     Text format     Abstract available
    
    
36. CASEY RT, Giger O, Seetho I, Marker A, et al
    Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab.
    Semin Oncol. 2018;45:151-155.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: